Effectiveness of single-dose 6 mg pegfilgrastim in mobilizing peripheral blood stem cells in allogeneic hematopoietic cell transplantation donors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effectiveness of single-dose 6 mg pegfilgrastim in mobilizing peripheral blood stem cells in allogeneic hematopoietic cell transplantation donors

Published:2023-09-29 Issue:12 Volume:102 Page:3567-3573
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Cao Junjie,Li Aizhen^ORCID,Pei Renzhi,Lu Ying,Chen Dong,Du Xiaohong,Liu Xuhui,Li Shuangyue,Ye Peipei

Funder

Ningbo Public welfare project

Ningbo Social and Development project

Yinzhou District Social and Development project

Zhejiang Medical Health Science and Technology Project

Ningbo Medical & Health Leading Academic Discipline Project

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00277-023-05469-y.pdf

Reference22 articles.

1. Schmitz N, Dreger P, Suttorp M et al (1995) Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 85:1666–1672. https://doi.org/10.1182/blood.V85.6.1666

2. Kröger N, Zander AR (2002) Dose and schedule effect of G-GSF for stem cell mobilization in healthy donors for allogeneic transplantation. Leuk Lymphoma 43:1391–1394. https://doi.org/10.1080/10428190290033323

3. Curran MP, Goa KL (2002) Pegfilgrastim. Drugs 62:1207–1213; discussion 1214-5. https://doi.org/10.2165/00003495-200262080-00012

4. Bond TC, Szabo E, Gabriel S et al (2018) Meta-analysis and indirect treatment comparison of lipegfilgrastim with pegfilgrastim and filgrastim for the reduction of chemotherapy-induced neutropenia-related events. J Oncol Pharm Pract 24:412–423. https://doi.org/10.1177/1078155217714859

5. Link H, Thompson SF, Tian M et al (2022) A comparative assessment of neutropenia events, healthcare resource use, and costs among cancer patients treated with lipegfilgrastim compared with pegfilgrastim in Germany. Support Care Cancer 30:9317–9327. https://doi.org/10.1007/s00520-022-07353-3

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3